These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 10900238)

  • 1. Protein kinase C and phosphatase inhibitors block the ability of angiotensin I-converting enzyme inhibitors to resensitize the receptor to bradykinin without altering the primary effects of bradykinin.
    Marcic BM; Erdös EG
    J Pharmacol Exp Ther; 2000 Aug; 294(2):605-12. PubMed ID: 10900238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the actions of bradykinin by angiotensin I-converting enzyme inhibitors. The role of expressed human bradykinin B2 receptors and angiotensin I-converting enzyme in CHO cells.
    Minshall RD; Tan F; Nakamura F; Rabito SF; Becker RP; Marcic B; Erdös EG
    Circ Res; 1997 Nov; 81(5):848-56. PubMed ID: 9351459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of bradykinin and resensitization of its B2 receptor.
    Marcic B; Deddish PA; Jackman HL; Erdös EG
    Hypertension; 1999 Mar; 33(3):835-43. PubMed ID: 10082496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replacement of the transmembrane anchor in angiotensin I-converting enzyme (ACE) with a glycosylphosphatidylinositol tail affects activation of the B2 bradykinin receptor by ACE inhibitors.
    Marcic B; Deddish PA; Skidgel RA; Erdös EG; Minshall RD; Tan F
    J Biol Chem; 2000 May; 275(21):16110-8. PubMed ID: 10748135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neprilysin inhibitors potentiate effects of bradykinin on b2 receptor.
    Deddish PA; Marcic BM; Tan F; Jackman HL; Chen Z; Erdös EG
    Hypertension; 2002 Feb; 39(2 Pt 2):619-23. PubMed ID: 11882619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mode of action of angiotensin I converting enzyme inhibitors: direct activation of bradykinin B1 receptor.
    Ignjatovic T; Tan F; Brovkovych V; Skidgel RA; Erdös EG
    J Biol Chem; 2002 May; 277(19):16847-52. PubMed ID: 11880373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrolysis of angiotensin peptides by human angiotensin I-converting enzyme and the resensitization of B2 kinin receptors.
    Chen Z; Tan F; Erdös EG; Deddish PA
    Hypertension; 2005 Dec; 46(6):1368-73. PubMed ID: 16246972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitor ramiprilat interferes with the sequestration of the B2 kinin receptor within the plasma membrane of native endothelial cells.
    Benzing T; Fleming I; Blaukat A; Müller-Esterl W; Busse R
    Circulation; 1999 Apr; 99(15):2034-40. PubMed ID: 10209009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors.
    Scharfstein J; Schmitz V; Morandi V; Capella MM; Lima AP; Morrot A; Juliano L; Müller-Esterl W
    J Exp Med; 2000 Nov; 192(9):1289-300. PubMed ID: 11067878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin-(1-7) potentiates responses to bradykinin but does not change responses to angiotensin I.
    Greco AJ; Master RG; Fokin A; Baber SR; Kadowitz PJ
    Can J Physiol Pharmacol; 2006 Nov; 84(11):1163-75. PubMed ID: 17218981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the angiotensin-converting enzyme and the kinin B2 receptor in the rabbit jugular vein: modulation of contractile response to bradykinin.
    Gobeil F; Hallé S; Blais PA; Regoli D
    Can J Physiol Pharmacol; 2002 Feb; 80(2):153-63. PubMed ID: 11934258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of bradykinin B1 receptor by ACE inhibitors.
    Ignjatovic T; Tan F; Brovkovych V; Skidgel RA; Erdös EG
    Int Immunopharmacol; 2002 Dec; 2(13-14):1787-93. PubMed ID: 12489793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the N-terminal sequence of ACE on the properties of its C-domain.
    Marcic B; Deddish PA; Jackman HL; Erdös EG; Tan F
    Hypertension; 2000 Jul; 36(1):116-21. PubMed ID: 10904022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transactivation of KDR/Flk-1 by the B2 receptor induces tube formation in human coronary endothelial cells.
    Miura S; Matsuo Y; Saku K
    Hypertension; 2003 May; 41(5):1118-23. PubMed ID: 12654712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human bradykinin B(2) receptor is activated by kallikrein and other serine proteases.
    Hecquet C; Tan F; Marcic BM; Erdös EG
    Mol Pharmacol; 2000 Oct; 58(4):828-36. PubMed ID: 10999954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands.
    Ignjatovic T; Stanisavljevic S; Brovkovych V; Skidgel RA; Erdös EG
    Mol Pharmacol; 2004 Nov; 66(5):1310-6. PubMed ID: 15304551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitor potentiation of bradykinin-induced venoconstriction.
    Hecker M; Blaukat A; Bara AT; Müller-Esterl W; Busse R
    Br J Pharmacol; 1997 Aug; 121(7):1475-81. PubMed ID: 9257930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.
    Deddish PA; Marcic B; Jackman HL; Wang HZ; Skidgel RA; Erdös EG
    Hypertension; 1998 Apr; 31(4):912-7. PubMed ID: 9535414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ca2+ release and Ca2+ influx in Chinese hamster ovary cells expressing the cloned mouse B2 bradykinin receptor: tyrosine kinase inhibitor-sensitive and- insensitive processes.
    Taketo M; Yokoyama S; Kimura Y; Higashida H
    Biochim Biophys Acta; 1997 Jan; 1355(1):89-98. PubMed ID: 9030205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.